Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection

University of Alabama at Birmingham731 enrolled

Overview

The purpose of the study is to collect pancreatic tissue, blood and urine from adults to study pancreatic abnormalities.

The aim of the study is to standardize, collect and share pancreatic cancer related information, to be used for research purposes only by researchers from different participating institutions/centers.

Study Type

OBSERVATIONAL

Enrollment

731

Conditions

Pancreatic Cancer

Eligibility

Sex: ALLMin age: 19 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Person over 19 years of age, patient with a tissue-proven diagnosis of pancreatic cancer at the University of Alabama at Birmingham (UAB) University Hospital during the period, and cognitive ability to provide informed consent Exclusion Criteria: * Person not 19 or older and have not had a tissue-proven diagnosis of pancreatic cancer.

Locations (1)

University of Alabama at Birmingham

Birmingham, Alabama, United States

Outcomes

Primary Outcomes

To diagnose Pancreatic Cancer

Time frame: 5 years

Secondary Outcomes

Preventing patient form being misdiagnosed

Time frame: 5 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.